Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Leuprorelin oral - Enteris BioPharma

Drug Profile

Leuprorelin oral - Enteris BioPharma

Alternative Names: Leuprolide acetate oral - Enteris BioPharma; Ovarest

Latest Information Update: 10 Jul 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Unigene Laboratories
  • Developer Enteris BioPharma; Unigene Laboratories
  • Class Antineoplastics; Gonadotropins; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
  • Mechanism of Action Gonadotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Endometriosis
  • Discontinued Precocious puberty; Prostate cancer; Uterine leiomyoma

Most Recent Events

  • 26 Jun 2018 Pharmacodynamics and Pharmacokinetics data from a phase IIa trial in Endometriosis released by Enteris BioPharma
  • 18 Jun 2018 Enteris BioPharma completes a phase II trial for Endometriosis (In healthy volunteers) in Canada (PO) (NCT02807363)
  • 30 Apr 2018 Enteris BioPharma completes enrolment in its additional arm of phase IIa trial in healthy volunteers
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top